Option framework for the valuation of biopharmaceutical companies
von Stefan Wörner
| Year of publication: |
2001
|
|---|---|
| Authors: | Wörner, Stefan |
| Subject: | Pharmaindustrie | Pharmaceutical industry | Biotechnologie-Industrie | Biotechnology industry | Unternehmensbewertung | Firm valuation | Biotechnologie | Biotechnology | Investition | Investment | Optionspreistheorie | Option pricing theory | Theorie | Theory | USA | United States | Pharmakologie | Pharmacology | Realoptionsansatz | Real options analysis | Unternehmen | Biopharmazie | Pharmazeutische Industrie | Forschung und Entwicklung |
| Description of contents: | Table of Contents [gbv.de] |
| Extent: | VIII, 149 S graph. Darst |
|---|---|
| Type of publication: | Book / Working Paper |
| Type of publication (narrower categories): | Hochschulschrift ; Graue Literatur ; Non-commercial literature ; Thesis |
| Language: | English |
| Thesis: | Karlsruhe, Univ., Diss., 2001 |
| Classification: | Pharmazie, Pharmazeutika ; Wirtschaftssektoren: Allgemeines |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10001640764